No abstract

Rechargeable Zn‐ion batteries (ZIBs) are widely regarded as promising candidates for large‐scale energy storage applications. Like most multivalent battery systems (based on Zn, Mg, Ca, etc.), further progress in ZIB development relies on the discovery and design of novel cathode hosts capable of reversible Zn2+ (de)intercalation. Herein, this work employs VPO4F as a ZIB cathode and explores ensuing intercalation mechanisms along with interfacial dynamics during cycling to quantify the water dynamics in concentrated electrolytes and/or hybrid aqueous‐non aqueous (HANEs) electrolyte(s). Like most oxide‐based cathode materials, proton (H+) intercalation dominates electrochemical activity during discharge of ZnxHyVPO4F in aqueous media due to the hydroxylated nature of the interface. Such H+ electrochemistry diminishes low‐rate and/or long‐term electrochemical performance of ZIBs which inhibits implementation for practical applications. Thus, quantification of the water dynamics in various electrolytes is demonstrated for the first time. Detailed investigations of water mobility in various concentrated electrolytes and HANEs systems enable the design of an electrolyte that enhances aqueous anodic stability and suppresses water/proton activity during discharge. Tuning Zn2+/H+ intercalation kinetics simultaneously allows for a high voltage (1.9 V) and long‐lasting aqueous zinc‐ion battery: Zn|Zn(OTf)2·nH2O‐PC|ZnxHyVPO4F.

Purpose: Computed Tomography (CT) imaging of the lung, reported in Hounsfield Units (HU), can be parameterized as a quantitative image biomarker for the diagnosis and monitoring of lung density changes due to emphysema, a type of chronic obstructive pulmonary disease (COPD). CT lung density metrics are global measurements based on lung CT number histograms, and are typically a quantity specifying either the percentage of voxels with CT numbers below a threshold, or a single CT number below which a fixed relative lung volume, nth percentile, falls. To reduce variability in the density metrics specified by CT attenuation, the Quantitative Imaging Biomarkers Alliance (QIBA) Lung Density Committee has organized efforts to conduct phantom studies in a variety of scanner models to establish a baseline for assessing the variations in patient studies that can be attributed to scanner calibration and measurement uncertainty. Methods: Data were obtained from a phantom study on CT scanners from four manufacturers with several protocols at various tube potential voltage (kVp) and exposure settings. Free from biological variation, these phantom studies provide an assessment of the accuracy and precision of the density metrics across platforms solely due to machine calibration and uncertainty of the reference materials. The phantom used in this study has three foam density references in the lung density region, which, after calibration against a suite of Standard Reference Materials (SRM) foams with certified physical density, establishes a HU-electron density relationship for each machine-protocol. We devised a 5-step calibration procedure combined with a simplified physical model that enabled the standardization of the CT numbers reported across a total of 22 scanner-protocol settings to a single energy (chosen at 80 keV). A standard deviation was calculated for overall CT numbers for each density, as well as by scanner and other variables, as a measure of the variability, before and after the standardization. In addition, a linear mixed-effects model was used to assess the heterogeneity across scanners, and the 95% confidence interval of the mean CT number was evaluated before and after the standardization. Results: We show that after applying the standardization procedures to the phantom data, the instrumental reproducibility of the CT density measurement of the reference foams improved by more than 65%, as measured by the standard deviation of the overall mean CT number. Using the lung foam that did not participate in the calibration as a test case, a mixed effects model analysis shows that the 95% confidence intervals are [–862.0 HU, –851.3 HU] before standardization, and [−859.0 HU, –853.7 HU] after standardization to 80 keV. This is in general agreement with the expected CT number value at 80 keV of –855.9 HU with 95% CI of [–857.4 HU, –854.5 HU] based on the calibration and the uncertainty in the SRM certified density. Conclusions: This study provides a quantitative assessment of the variations expected in CT ...

A major initiative of the Quantitative Imaging Biomarker Alliance (QIBA) is to develop standards-based documents called “Profiles”, which describe one or more technical performance claims for a given imaging modality. The term “actor” denotes any entity (device, software, person) whose performance must meet certain specifications in order for the claim to be met. The objective of this paper is to present the statistical issues in testing actors’ conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient (ADC) in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by CT as a biomarker for lung cancer progression.